Publications by authors named "Jane Box"

Claim this Profile
A
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.
Cynthia Aranow, John Cush, Marcy B Bolster, Christopher C Striebich, Maria Dall'era, Jane Box

Rheumatology (Oxford)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial.
Mark C Genovese, César Pacheco-Tena, Arturo Covarrubias, Gustavo Leon, Eduardo Mysler, Jane Box

J Rheumatol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous abatacept for the treatment of rheumatoid arthritis: longterm data from the ACQUIRE trial.
Mark C Genovese, César Pacheco Tena, Arturo Covarrubias, Gustavo Leon, Eduardo Mysler, Jane Box

J Rheumatol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study.
Edward Clark Keystone, Joel M Kremer, Anthony Russell, Jane Box, Carlos Abud-Mendoza

Ann Rheum Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
Mark C Genovese, Jean-Claude Becker, Michael Schiff, Michael Luggen, Yvonne Sherrer, Jane Box

N Engl J Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis